GRX-917 (deuterated etifoxine) was well-tolerated with no dose-limiting toxicities and only mild adverse effects comparable to that of placebo in both single and multiple ascending doses, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback